HYBRID EVENT: You can participate in person at Orlando, USA or Virtually from your home or work.

6th Edition of International Conference on Neurology and Brain Disorders

October 24 -26, 2022

October 24 -26, 2022 | Orlando, Florida, USA
INBC 2022

Jose Iranildo Sales

Speaker at Neurology and Brain Disorders 2022 - Jose Iranildo Sales
Mauricio de Nassau University of Medicine, Brazil
Title : Studies with the use of the Hyperbaric Oxygen Therapy (HBOT) and its influence on cerebral Neuroplasty: Effects after ischemic and hemorrhagic stroke.


Background: Recent studies have raised the possibility and clinical feasibility of using treatments using oxygen therapies in hyperbaric chambers (HBOT) for the analysis of functional and cognitive improvements in patients after ischemic and hemorrhagic strokes. The effects in cerebral neuroplasty due to programmed pressure variation in the damaged areas can and has been a factor of improvement in the clinical picture of several patients with the use of clinical trials around the world.

Objective: The objective of this study is to evaluate the effects of oxygen therapy in hyperbaric chambers (HBOT) on the cognitive and general motor functions of post-ischemic and hemorrhagic stroke patients.

Methods: A prospective analysis will be performed on patients who were treated with HBOT for ischemic or hemorrhagic stroke (>4 months) in 2022. Participants will be treated in a hyperbaric chamber with the following protocols: 40 to 60 sessions daily, 5 days a week, each session included 90 min of 100% oxygen at 2 ATA with 5 min air brakes every 20 min. Clinically significant improvements (CSI) were defined as > 0.5 standard deviation (SD). 120 patients with ischemic and hemorrhagic stroke will be used in two groups in which one parcel will be submitted to a hyperbaric chamber and the other parcels will not undergo the intervention in order to analyze the impact.

Expected Results: The results will be demonstrated at the end of the prospective study proposed by this study. It is expected that the introduction of hyperbaric therapy (HBOT) in patients with hemorrhagic or ischemic strokes will bring structural changes in the areas damaged by the disease and can bring cognitive and motor gains to the patients analyzed.

What will audience learn from your presentation?

  • The use of hyperbaric therapy (HBOT) could help the main medical centers in the world to improve the quality of life of patients after ischemic or hemorrhagic strokes.
  • The cognitive and functional improvement of patients resulting from neuroplasty caused by the therapy will serve as a basis for new studies that may improve the procedure already applied to some areas of medicine.
  • Studies directly related to neurological rehabilitation will gain another tool to improve the quality of life in the cognitive and motor aspects of treated patients.


Mr. Jose Iranildo Sales medicine student at Uninassau, Brazil. He is then also holds a master's degree (2016) and PhD degree (2021) in Production Engineering from the Federal University of Pernambuco. Graduated in Business

Administration from the University of Pernambuco (2013). Currently associated with the research department of the Mauricio de Nassau University of Medicine. Ms. Maria Gerliane Cavalcante medicine student at Uninassau, Brazil. She then also holds a master's degree in software engineering from the (CESAR) Center for Advanced Studies and Research of Recife (2021), graduated in Business Administration from the University of Pernambuco (2014). Both with international publications.